Ascentage Pharma Group International (AAPG)
NASDAQ: AAPG · Real-Time Price · USD
23.17
-1.01 (-4.18%)
Feb 2, 2026, 4:00 PM EST - Market closed
AAPG Market Cap
AAPG has a market cap or net worth of $2.14 billion as of February 2, 2026. Its market cap has increased by 35.60% in one year.
Market Cap
2.14B
Enterprise Value
2.15B
1-Year Change
35.60%
Ranking
Category
Stock Price
$23.17
Market Cap Chart
Since the IPO on June 13, 2022, AAPG's market cap has increased from $554.36M to $2.14B, an increase of 286.12%. That is a compound annual growth rate of 44.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 2, 2026 | 2.14B | -13.36% |
| Dec 31, 2025 | 2.47B | 36.38% |
| Dec 31, 2024 | 1.81B | 82.20% |
| Dec 29, 2023 | 994.30M | 16.90% |
| Dec 30, 2022 | 850.58M | 53.44% |
| Jun 13, 2022 | 554.36M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Mineralys Therapeutics | 2.44B |
| Wave Life Sciences | 2.37B |
| Ultragenyx Pharmaceutical | 2.32B |
| Dianthus Therapeutics | 2.29B |
| Mesoblast | 2.28B |
| Galapagos NV | 2.23B |
| Recursion Pharmaceuticals | 2.18B |
| Sarepta Therapeutics | 2.13B |